UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 167

Sortiert nach

Impact of the 21-gene assay in decision-making during multidisciplinary breast meeting: A French experience

Gynécologie, obstétrique & fertilité, 2015-12, Vol.43 (12), p.780-785

2015

Link zum Volltext

Verfügbarkeit prüfen

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Haematologica (Roma), 2010-03, Vol.95 (3), p.415-423

2010

Link zum Volltext

Verfügbarkeit prüfen

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Haematologica (Roma), 2009-12, Vol.94 (12), p.1676-1681

2009

Link zum Volltext

Verfügbarkeit prüfen

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Nature Medicine, 2020-03, Vol.26 (3), p.398-407

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Cancer epidemiology, biomarkers & prevention, 2012-01, Vol.21 (1), p.134-147

2012

Link zum Volltext

Verfügbarkeit prüfen

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

Blood, 2005-05, Vol.105 (10), p.4035-4042

2005

Link zum Volltext

Verfügbarkeit prüfen

Behavioral assessment of unilateral neglect: Study of the psychometric properties of the Catherine Bergego Scale

Archives of physical medicine and rehabilitation, 2003, Vol.84 (1), p.51-57

2003

Link zum Volltext

Verfügbarkeit prüfen

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

Haematologica (Roma), 2011-07, Vol.96 (7), p.1059-1063

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of radial forearm flap and thoracodorsal artery perforator flap donor site morbidity for reconstruction of oral and oropharyngeal defects in head and neck cancer

European annals of otorhinolaryngology, head and neck diseases, 2015-09, Vol.132 (4), p.185-189

2015

Link zum Volltext

Verfügbarkeit prüfen

Accelerated functional brain aging in pre-clinical familial Alzheimer's disease

Nature communications, 2021-09, Vol.12 (1), p.5346-5346, Article 5346

2021

Link zum Volltext

Verfügbarkeit prüfen

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

Blood, 2002-03, Vol.99 (5), p.1594-1601

2002

Link zum Volltext

Verfügbarkeit prüfen

Arrhythmia Discrimination in Implantable Cardioverter Defibrillators Using Support Vector Machines Applied to a New Representation of Electrograms

IEEE transactions on biomedical engineering, 2011-06, Vol.58 (6), p.1797-1803

2011

Link zum Volltext
IEEE_Xplore

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Nature communications, 2021-02, Vol.12 (1), p.1078-22, Article 1078

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Blood, 2001-10, Vol.98 (8), p.2319-2325

2001

Link zum Volltext

Verfügbarkeit prüfen

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9742-9754

2010

Link zum Volltext

Verfügbarkeit prüfen

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies

American journal of human genetics, 2007-12, Vol.81 (6), p.1186-1200

2007

Link zum Volltext

Verfügbarkeit prüfen

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Blood cancer journal (New York), 2017-06, Vol.7 (6), p.e568-e568

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 167

Suche als RSS-Feed

Aktive Filter

KollektionOvid

KollektionSpringerLink (Online service)

Nur zeigenMit Volltextzugriff

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)

Publikationsform

Artikel
(167)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(167)
Male
(124)
Female
(121)
Adult
(112)
Aged
(88)
Science & Technology
(72)
Life Sciences & Biomedicine
(68)
Hematology
(33)
Adolescent
(32)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Aged, 80 And Over
(26)
Follow-Up Studies
(17)
Prognosis
(17)
Hematologic And Hematopoietic Diseases
(15)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(15)
Oncology
(15)
Survival Rate
(14)
Life Sciences
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of the 21-gene assay in decision-making during multidisciplinary breast meeting: A French experience

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

Behavioral assessment of unilateral neglect: Study of the psychometric properties of the Catherine Bergego Scale

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

Comparison of radial forearm flap and thoracodorsal artery perforator flap donor site morbidity for reconstruction of oral and oropharyngeal defects in head and neck cancer

Accelerated functional brain aging in pre-clinical familial Alzheimer's disease

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies

Arrhythmia Discrimination in Implantable Cardioverter Defibrillators Using Support Vector Machines Applied to a New Representation of Electrograms

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Aktive Filter

Suchergebnisse filtern